Risk Factors
437 articles
Traveling with Pancreatic Cancer
Drs. Sunil Hingorani and David Zhen outline the ways to make traveling with pancreatic cancer easier if you are in treatment.
COVID-19: What You Should Do Now
Learn what you should do to prevent the spread of COVID-19, especially if you have a weakened immune system from pancreatic cancer treatment.
New Prospective Clinical Study of Blood-Based Early Detection Test
Dr. Rosalie Sears is working with Biological Dynamics to test a new early detection blood assay and platform for pancreatic cancer screening.
Common Anti-Anxiety Medications May Affect Outcomes
Many pancreatic cancer patients take anti-anxiety medications. But what you take may affect how your treatment works, says Dr. Michael Feigin.
Navigating Cold and Flu Season as a Cancer Patient
Are you in treatment and planning to see friends or family for the holidays? Learn the best ways to protect yourself from cold, flu, and other viruses.
Adapting Cancer Medicine Is Key Part of Containing COVID-19
In an interview with OncLive, Dr. Allyson Ocean discusses the risks faced by cancer patients in treatment during the COVID-19 pandemic.
Pancreatic Cancer and Drug Interactions: What You Need to Know
Pharmacist Trevor Christ emphasizes the importance of sharing your medication list with your medical team and pharmacist.
Shedding Light on Chemo Brain
What is chemo fog or chemo brain? Are there techniques to counteract the side effects of chemotherapy on the brain?
Important Questions When Starting Pancreatic Cancer Treatment
Dr. Gauri Varadhachary outlines the important questions to ask when you start treatment with surgery, chemotherapy, or radiation for pancreatic cancer.
The Butterfly Effect and Living Every Day to My Fullest
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
My Journey with Pancreatic Cancer
Dr. Robert Wagar lost both parents to pancreatic cancer. When his wife found an article about a surveillance study he had an MRI, which found a lesion.
Solving the Mystery of Cachexia
Researchers are looking for ways to combat cachexia, the metabolic syndrome that causes weight and muscle loss in people with cancer and other diseases.
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
Meet the Researcher: Hiroyuki Kato, M.D., Ph.D.
Researcher Dr. Hiroyuki Kato has traveled from Japan to Boston for his research on IPMNs and pancreatic cancer.